Foundry Partners, LLC Concert Pharmaceuticals, Inc. Transaction History

Foundry Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 22, 2019	SELL	$12.07 - $17.54 $448,460 - $651,698	-37,155 Closed	0 $0
Q4 2018 Jan 10, 2019	BUY	$11.25 - $16.17 $708 - $1,018	63 Added 0.17%	37,155 $551,000
Q4 2018 Jan 10, 2019	SELL	$11.25 - $16.17 $708 - $1,018	-63 Reduced 0.17%	37,092 $466,000
Q3 2018 Oct 17, 2018	SELL	$12.82 - $17.88 $730 - $1,019	-57 Reduced 0.15%	37,155 $551,000
Q2 2018 Jul 19, 2018	BUY	$16.83 - $21.66 $626,277 - $806,011	37,212 New	37,212 $626,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.